Hersh EM - Search Results

1

Immunologic aspects of interstitial cystitis.

Gordon HL, Rossen RD, Hersh EM, Yium JJ. Gordon HL, et al. Among authors: hersh em. J Urol. 1973 Feb;109(2):228-33. doi: 10.1016/s0022-5347(17)60393-8. J Urol. 1973. PMID: 4568310 No abstract available.

2

Radioimmunological imaging of metastatic prostatic cancer with 111indium-labeled monoclonal antibody PAY 276.

Babaian RJ, Murray JL, Lamki LM, Haynie TP, Hersh EM, Rosenblum MG, Glenn HJ, Unger MW, Carlo DJ, von Eschenbach AC. Babaian RJ, et al. Among authors: hersh em. J Urol. 1987 Mar;137(3):439-43. doi: 10.1016/s0022-5347(17)44060-2. J Urol. 1987. PMID: 3820371

3

Pharmacokinetics of 111In-labeled anti-p97 monoclonal antibody in patients with metastatic malignant melanoma.

Rosenblum MG, Murray JL, Haynie TP, Glenn HJ, Jahns MF, Benjamin RS, Frincke JM, Carlo DJ, Hersh EM. Rosenblum MG, et al. Among authors: hersh em. Cancer Res. 1985 May;45(5):2382-6. Cancer Res. 1985. PMID: 3986780

4

Radioimmunoimaging in malignant melanoma patients with the use of indium-111-labeled antimelanoma monoclonal antibody (ZME-018) to high-molecular-weight antigen.

Murray JL, Rosenblum MG, Lamki L, Haynie TP, Glenn HJ, Plager CE, Unger MW, Carlo DJ, Hersh EM. Murray JL, et al. Among authors: hersh em. NCI Monogr. 1987;(3):3-9. NCI Monogr. 1987. PMID: 3821916

5

Clinical parameters related to optimal tumor localization of indium-111-labeled mouse antimelanoma monoclonal antibody ZME-018.

Murray JL, Rosenblum MG, Lamki L, Glenn HJ, Krizan Z, Hersh EM, Plager CE, Bartholomew RM, Unger MW, Carlo DJ. Murray JL, et al. Among authors: hersh em. J Nucl Med. 1987 Jan;28(1):25-33. J Nucl Med. 1987. PMID: 3794809

6

BCG stimulation of immune responsiveness in patients with malignant melanoma. Preliminary report.

Gutterman J, Mavligit G, McBride C, Frei E 3rd, Hersh EM. Gutterman J, et al. Among authors: hersh em. Cancer. 1973 Aug;32(2):321-7. doi: 10.1002/1097-0142(197308)32:2<321::aid-cncr2820320207>3.0.co;2-y. Cancer. 1973. PMID: 4722915 No abstract available.

7

The use of leukocyte cell line culture supernatant for skin reaction testing in malignant melanoma.

Rios A, Hersh EM, Gutterman JU, Mavligit GM, Schimek H, McEntire JE, Papermaster BW. Rios A, et al. Among authors: hersh em. Cancer. 1979 Nov;44(5):1615-21. doi: 10.1002/1097-0142(197911)44:5<1615::aid-cncr2820440512>3.0.co;2-q. Cancer. 1979. PMID: 498033

8

Actinomycin-D plus 5-(3,3-dimethyl-1-triazeno)-imidazole-4-carboxamine (DTIC) with or without intravenous Corynebacterium parvum in metastatic malignant melanoma.

Robidoux A, Gutterman JU, Bodey GP Sr, Hersh EM. Robidoux A, et al. Among authors: hersh em. Cancer. 1982 Jun 1;49(11):2246-51. doi: 10.1002/1097-0142(19820601)49:11<2246::aid-cncr2820491108>3.0.co;2-d. Cancer. 1982. PMID: 7042068 Clinical Trial.

9

Prognostic correlations and response to treatment in advanced metastatic malignant melanoma.

Einhorn LH, Burgess MA, Vallejos C, Bodey GP Sr, Gutterman J, Mavligit G, Hersh EM, Luce JK, Frei E 3rd, Freireich EJ, Gottlieb JA. Einhorn LH, et al. Among authors: hersh em. Cancer Res. 1974 Aug;34(8):1995-2004. Cancer Res. 1974. PMID: 4842252 No abstract available.

10

The natural history of resectable metastatic melanoma (Stage IVA melanoma).

Feun LG, Gutterman J, Burgess MA, Hersh EM, Mavligit G, McBride CM, Benjamin RS, Richman SP, Murphy WK, Bodey GP, Brown BW, Mountain CF, Leavens ME, Freireich EJ. Feun LG, et al. Among authors: hersh em. Cancer. 1982 Oct 15;50(8):1656-63. doi: 10.1002/1097-0142(19821015)50:8<1656::aid-cncr2820500833>3.0.co;2-l. Cancer. 1982. PMID: 7116298

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results